Potential coverage of a multivalent M protein-based group A streptococcal vaccine

► Multivalent group A streptococcal vaccine. ► Extended vaccine coverage to include non-vaccine serotypes of group A streptococci. ► Potential protection in a population at high risk for RHD. ► Potential for vaccine prevention of GAS infections that may trigger acute rheumatic fever.